Pierre Paul Bringuier

Prognostic value of cadherin-associated molecules (alpha-, beta-, and gamma-catenins and p120cas) in bladder tumors.

Toru Shimazui, Jack A. Schalken, Laurence A. Giroldi et al. · PubMed · 1996 · 205 citations · Full text

Medicine, Cell Biology, Oncology +11

Biomarkers (BM) France: Results of routine EGFR, HER2, KRAS, BRAF, PI3KCA mutations detection and EML4-ALK gene fusion assessment on the first 10,000 non-small cell lung cancer (NSCLC) patients (pts).

Fabrice Barlési, Hélène Blons, Michèle Beau‐Faller et al. · Journal of Clinical Oncology · 2013 · 112 citations

Medicine, Oncology, Pathology +17

Relation between aberrant α-catenin expression and loss of E-cadherin function in prostate cancer

Rainy Umbas, William B. Isaacs, Pierre Paul Bringuier et al. · International Journal of Cancer · 1997 · 92 citations

Medicine, Oncology, Urology +17

Cross-platform comparison for the detection of RAS mutations in cfDNA (ddPCR Biorad detection assay, BEAMing assay, and NGS strategy)

Jessica Garcia, Julien Forestier, Eric Dusserre et al. · Oncotarget · 2018 · 56 citations · Full text

Life Sciences, Genetics, Molecular Genetics +14

Decreased expression of α-catenin is associated with poor prognosis of patients with localized renal cell carcinoma

Toru Shimazui, Pierre Paul Bringuier, H. Berkel et al. · International Journal of Cancer · 1997 · 48 citations · Full text

Medicine, Oncology, Pathology +17